During the past decade, ASST Monza - Ospedale San Gerardo conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 14 clinical trials were completed, i.e. on average, 16.5% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 12 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASST Monza - Ospedale San Gerardo" #1 sponsor was "University of Milano Bicocca" with 31 trials, followed by "Celgene" with 5 trials sponsored, "Daiichi Sankyo, Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASST Monza - Ospedale San Gerardo" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Clinical Research Technology S.r.l." with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Azienda Ospedaliera San Gerardo di Monza" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "ASST Monza - Ospedale San Gerardo" are "Breast Cancer" (7 trials), "Non-Small Cell Lung Cancer" (5 trials), "Covid19" (4 trials), "Crohn Disease" (3 trials) and "Lung Diseases" (3 trials). Many other conditions were trialed in "ASST Monza - Ospedale San Gerardo" in a lesser frequency.

Most popular intervention types in "ASST Monza - Ospedale San Gerardo" are "Drug" (63 trials), "Other" (16 trials), "Procedure" (6 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (6 trials), "Atezolizumab" (4 trials), "Cisplatin" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "ASST Monza - Ospedale San Gerardo" are 84 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "ASST Monza - Ospedale San Gerardo". undefined are not yet recruiting, 29 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in ASST Monza - Ospedale San Gerardo, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in ASST Monza - Ospedale San Gerardo, 4 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

ASST Monza - Ospedale San Gerardo has several departments that took part in Clinical trials: "ASST DI MONZA; Oncologia Medica" - 15 trials, "Ospedale San Gerardo - U.O. Cardiologia-Utic" - 5 trials, "ASST DI MONZA; Neurologia" - 3 trials, "ASST Monza - Ospedale San Gerardo; Clinica Nefrologica" - 2 trials, "ASST DI MONZA; U O Clinica Pneumologica" - 2 trials, "Unità operativa di Anestesia e Rianimazione - Azienda Ospedaliera San Gerardo" - 2 trials